Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Xtract One ( (TSE:XTRA) ).
Xtract One Technologies has been chosen by San Mateo Medical Center in California to deploy its SmartGateway system, enhancing security with AI-powered weapon detection. This initiative aligns with California’s new mandate for hospital weapons detection, aiming to improve safety and reduce disruptions, thereby positioning San Mateo Medical Center as a proactive leader in healthcare security.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.50 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Spark’s Take on TSE:XTRA Stock
According to Spark, TipRanks’ AI Analyst, TSE:XTRA is a Neutral.
Xtract One’s overall score is driven by financial performance challenges, notably in profitability and cash flow, which are significant concerns. Technical analysis indicates bearish market sentiment. Valuation is weak with no dividends and a negative P/E ratio. Although corporate events and earnings call highlight potential growth, the financial and technical weaknesses dominate the outlook.
To see Spark’s full report on TSE:XTRA stock, click here.
More about Xtract One
Xtract One Technologies is a leading provider of AI-powered threat detection and security solutions, focusing on enhancing safety and ensuring seamless experiences. The company offers unobtrusive weapons and threat detection systems designed for various facilities, including schools, hospitals, arenas, and more, allowing for discreet screening without disrupting traffic flow.
Average Trading Volume: 173,341
Technical Sentiment Signal: Sell
Current Market Cap: C$69.9M
Learn more about XTRA stock on TipRanks’ Stock Analysis page.